GSK2140944
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for GSK2140944, covering 2017-05-09 to 2017-09-21. Get the full timeline:
Most recent: Clinical Trial Update: Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections [Phase 2]